CALCA and Headache: Recommendations of international headache societies as the EHF or the American Headache Society (AHS) include offering CGRP-mAbs to patients with EM or CM who were unable to tolerate or showed an inadequate response to two of the evidence-based preventive treatments such as topiramate, beta-blockers or flunarizine [25–27].